Dr Bertrand Mennecier

Spécialité

Oncologue médical, expert poumon

Hôpital

Hôpitaux Universitaires de Strasbourg (Strasbourg)

Derniers articles

• Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation. (6 août 2024)
• Real-life clinical management patterns in extensive-stage small cell lung cancer across France: a multi-method study. (5 avr. 2024)
• 18FDG PET/CT Tumoral and Neurologic Therapeutic Response in a Case of Anti-GABABR Paraneoplastic Limbic Encephalitis. (1 mars 2023)
• Immunotherapy and Interventional Radiology: Two Optimal Allies in the Management of Bronchial Cancer. (1 déc. 2022)
• Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study. (30 mars 2022)